We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Comparative assessment of allergic reactions to COVID‐19 vaccines in Europe and the United States.
- Authors
Hatziantoniou, Sophia; Anastassopoulou, Cleo; Lampropoulou, Vicky; Maltezou, Helena C.; Andreakos, Evangelos; Poland, Gregory A.; Tsakris, Athanasios
- Abstract
Detailed demographic data and outcomes of anaphylactic reaction and anaphylactic shock cases post-COVID-19 vaccination are presented in Tables S1 and S2, respectively. The most common allergic reactions after COVID-19 vaccination were anaphylactic reactions, with an overall incidence of 9.91/million doses (EEA: 13.69/million/US: 4.44/million, Figure 1). Allergic reaction data following COVID-19 vaccination reported from Week 52/2020 to Week 39/2021 were collected from EudraVigilance for the European Economic Area (EEA) and from Vaccine Adverse Event Reporting System (VAERS) for the United States and analyzed for all licensed vaccines.
- Subjects
ALLERGIES; COVID-19 vaccines; ATOPY; VACCINE safety
- Publication
Allergy, 2022, Vol 77, Issue 5, p1630
- ISSN
0105-4538
- Publication type
Article
- DOI
10.1111/all.15257